EX-23.2 6 w45705ex23-2.htm CONSENT OF KPMG LLP ex23-2

Exhibit 23.2

Consent of Independent Auditors

The Board of Directors
Guilford Pharmaceuticals Inc.:

We consent to the use of our report incorporated herein by reference.

Philadelphia, Pennsylvania
February 21, 2001

  /s/ KPMG LLP
 
  KPMG LLP